Klinične študije za Migrena v New York
15 študij za Migrena išče udeležence na lokacijah v New York.
Mesta v New York
Uradno besedilo študije (angleško)
Study of EVO756 in Adults With Migraine
- Clinosis - Dent Neurologic Instite, Amherst
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- True North Neurology, Port Jefferson Station
Vključevanje udeležencevFaza 1
Starost 6–11 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Montefiore Medical Center, The Bronx
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05156398MMA Embolization for Refractory Chronic Migraine
- University of Buffalo Medical Center, Buffalo
- Mount Sinai, New York
- Stony Brook University Medical Center, Stony Brook
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06735833A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
- Maimonides Medical Center, Brooklyn
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06473597Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- New York Neurology Associates, New York
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- Northwell Health IRB, Great Neck
- in še 4
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Dent Neurologic Institute - Amherst /ID# 270260, Amherst
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dent Neurological Institute, Amherst
Vključevanje udeležencev
Starost 10–17 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nuvance Health Institute, Kingston
- Northwell Health, Manhasset
- Mt Sinai Icahn School of Medicine, New York
Vključevanje udeležencevFaza 4
Starost 18–70 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Dent Neurologic Institute - Amherst /ID# 231182, Amherst
- SUNY Upstate Medical University /ID# 239898, Syracuse
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Dent Neuro Institute, Buffalo, Amherst
- SPRI Clinical Trials, LLC, Brooklyn
- True North Neurology, Commack
- in še 4
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- True North Neurology, Commack
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT05164172Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
- Neuroscience Institute at Great Neck, Great Neck
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 22. maj 2026 · NCT07061847RELAXaHEAD for Headache Patients (Phase III)
- NYU Langone Health, New York
Vključevanje udeležencev
Starost 16–80 · Vsi spoli · Posodobljeno 10. okt. 2025 · NCT06077838Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.